Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

TNFR1 Blockade Rather then TNFR2 Blockade Reduces Chronic Inflammation in JAK2 +/V617F Mice

Peter Müller, PhD, Bärbel Edelmann-Stephan, PhD, Fabian Richter, PhD, Klaus Pfizenmaier, PhD, Thomas Fischer, MD

Blood (2019) 134 (Supplement_1): 2966.

https://doi.org/10.1182/blood-2019-127997

Published: 2019

Journal Articles

FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial

Blood (2019) 134 (Supplement_1): 4434.

https://doi.org/10.1182/blood-2019-130584

Published: 2019

Journal Articles

Preclinical Characterization of an ANTI-CD38/CD3 T CELL-Redirecting Bispecific Antibody

Xiao He, PhD, Yanliang Zhang, PhD, Yun Wei Lai, MSc, Stephanie Baguley, MSc, Yan Li, PhD, Xia Cao, MSc, Ying Yan, PhD, Ken Takeshita, MD, Jerome B. Zeldis, MD PhD, Henry Ji, PhD, Gunnar F. Kaufmann, PhD

Blood (2019) 134 (Supplement_1): 4463.

https://doi.org/10.1182/blood-2019-131540

Published: 2019

Journal Articles

The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia

Samah Nassereddine, MD, Kimberley Doucette, MD MSc, Vanya Aggarwal, Richard Amdur, PhD, Imad A. Tabbara, MD, Catherine E. Lai, MD

Blood (2019) 134 (Supplement_1): 2212.

https://doi.org/10.1182/blood-2019-124150

Published: 2019

Journal Articles

A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 2709.

https://doi.org/10.1182/blood-2019-122121

Published: 2019

Journal Articles

Donor Cell Acute Myeloid Leukemia after Transplant for Follicular Lymphoma

Lacey S. Williams, MD, Catherine E. Lai, MD

Blood (2019) 134 (Supplement_1): 5697.

https://doi.org/10.1182/blood-2019-122932

Published: 2019

Journal Articles

JAK2V617F Hematopoietic Stem and Progenitors Are More Resistant to Chronic Blockage of IL-10 Signaling in a Murine Model of Myeloproliferative Neoplasms

Hew Yeng Lai, PhD, Tiffany Trieu, Tiffany Han, Stefan Brooks, Brianna Craver, MS, Gajalakshmi Ramanathan, PhD, Angela G. Fleischman, MD PhD

Blood (2019) 134 (Supplement_1): 4206.

https://doi.org/10.1182/blood-2019-131166

Published: 2019

Journal Articles

FOXM1 and the NPM-ALK/STAT3 Axis Form a Novel Positive Feedback Loop in Promoting the Oncogenesis of ALK-Positive Anaplastic Large Cell Lymphoma

Peng Wang, MD PhD, Moinul Haque, Jing Li, Yung-Hsing Huang, Meaad Almowaled, Carter Bargar, Adam Karpf, Will Chen, Suzanne Turner, Raymond Lai, PhD MD

Blood (2018) 132 (Supplement 1): 3921.

https://doi.org/10.1182/blood-2018-99-115743

Published: 2018

Journal Articles

Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies

Blood (2018) 132 (Supplement 1): 4546.

https://doi.org/10.1182/blood-2018-99-116843

Published: 2018

Journal Articles

Insights from Comparative Serum Proteomic Profiling of Children with Sickle Cell Disease: The Effect of Hydroxyurea and Genotype on Protein Abundance

Susanne Ragg, MD PhD, Melissa Key, Fernanda Rankin, Monica L. Hulbert, MD

Blood (2016) 128 (22): 1302.

https://doi.org/10.1182/blood.V128.22.1302.1302

Published: 2016

Journal Articles

A Novel HIV Envelope Bi-Specific Killer Engager Enhances Natural Killer Cell Mediated ADCC Responses Against HIV-Infected Cells

Zachary B. Davis, PhD BS, Todd Lenvik, Louis Hansen, Martin Felices, PhD, Sarah Cooley, MD, Dan Vallera, PhD, Ashley T. Haase, MD, Richard A. Koup, MD, Daniel Douek, MD, Timothy Schacker, MD, Jeffrey S. Miller, MD

Blood (2016) 128 (22): 2517.

https://doi.org/10.1182/blood.V128.22.2517.2517

Published: 2016

Journal Articles

Predicting Cerdulatinib Therapeutic Concentrations in Patients with Relapsed/Refractory B Cell Malignancies Using Preclinical Models and Clinical PK/PD and Tumor Response Correlates

Greg P. Coffey, PhD, Jiajia Feng, MD, Glenn Michelson, MD, Janet Leads, PhD, John T. Curnutte, MDPhD, Anjali Pandey, PhD, Pamela B. Conley, PhD

Blood (2015) 126 (23): 3706.

https://doi.org/10.1182/blood.V126.23.3706.3706

Published: 2015

Journal Articles

CUDC-907, a Dual HDAC and PI3K Inhibitor, Potentially Targets Cancer Cells and The Microenvironment In Hematological Malignancies

Jing Wang, PhD, Natalie Pursell, PhD, Anna Ma, Ruzanna Atoyan, Maria Samson, Mylissa Borek, Steven DellaRocca, Ling Yin, Da-gong Wang, Brian Zifcak, Guang-xin Xu, Maurizio Voi, MD, Cheng-Jung Lai, PhD

Blood (2013) 122 (21): 4930.

https://doi.org/10.1182/blood.V122.21.4930.4930

Published: 2013

Journal Articles

Constitutive and Immunoproteasome Inhibitors Increase IκB and Decrease NF-κB Expression In Dendritic Cell

Ahmad-Samer Samer Al-Homsi, MD, Zhongbin Lai, MD, PhD, Tara Sabrina Roy, NP, Niholas Kouttab

Blood (2013) 122 (21): 3493.

https://doi.org/10.1182/blood.V122.21.3493.3493

Published: 2013

Journal Articles

A First-In-Man Phase 1 Study Of CUDC-907, a First-In-Class Chemically-Designed Dual Inhibitor Of PI3K and HDAC In Patients With Refractory Or Relapsed Lymphoma and Multiple Myeloma

Anas Younes, MD, Ian W. Flinn, MD, PhD, Yasuhiro Oki, MD, Amanda Copland, RN, MSN, CNS, Ali Fattaey, PhD, Cheng-Jung Lai, PhD, Robert Laliberte, MS, Maurizio Voi, MD, Jesus G Berdeja, MD

Blood (2013) 122 (21): 4363.

https://doi.org/10.1182/blood.V122.21.4363.4363

Published: 2013

Journal Articles

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Michelle A. Fanale, MD, Chao-Ming Lai, APN, Sue A Rimes, RN, Mildred M Ramirez, MD, Fredrick B Hagemeister, MD, Nathan H Fowler, MD, Anas Younes, MD, Luis E Fayad, MD, Maria Alma Rodriguez, MD, Francesco Turturro, MD, Felipe Samaniego, MD, MPH, Jorge E Romaguera, MD, Victor A Levin, MD, Sandra B Horowitz, PharmD, Joseph E Woolery, PharmD, Andrea Milbourne, MD

Blood (2012) 120 (21): 3670.

https://doi.org/10.1182/blood.V120.21.3670.3670

Published: 2012

Journal Articles

Spleen Tyrosine Kinase Inhibitor Fostamatinib Blocks B Cell Receptor Signaling and Reduces Viability of BCR Subtype Diffuse Large B Cell Lymphoma

Yue Zhang, Ph.D., Julie Parmentier, Zhongwu Lai, Ph.D., Greg O'Connor, Melissa Passino, Ph.D., Francoise Powell, Erik Devereaux, Kate Byth, Ph.D.

Blood (2012) 120 (21): 3720.

https://doi.org/10.1182/blood.V120.21.3720.3720

Published: 2012

Journal Articles

Harman AN, Lai J, Turville S, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood . 2011;118(2): 298-308 .

Blood (2011) 118 (26): 6992.

https://doi.org/10.1182/blood-2011-10-384719

Published: 2011

Journal Articles

Somatic Hypermutation in Mantle Cell Lymphoma

Jonathon B. Cohen, MD, Weiqiang Zhao, MD PhD, Amy S. Ruppert, MAS, Susan Long, Frederick Racke, MD, PhD, Kristie A. Blum, MD

Blood (2011) 118 (21): 5189.

https://doi.org/10.1182/blood.V118.21.5189.5189

Published: 2011

Journal Articles

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Anna Spasiano, Domenico Giuseppe D'Ascola, Aldo Filosa, Vincenzo Caruso, M.D., Paolo Cianciulli, M.D., Maria Antonietta Romeo, M.D., Maria Caterina Putti, MD, Angelo Peluso, Maria Grazia Bisconte, Maria Eliana Lai, Aurelio Maggio, MD, Cristina Salvatori, Massimo Lombardi, Marcello Capra, M.D.

Blood (2011) 118 (21): 5298.

https://doi.org/10.1182/blood.V118.21.5298.5298

Published: 2011

NARROW

TNFR1 Blockade Rather then TNFR2 Blockade Reduces Chronic Inflammation in JAK2 +/V617F Mice

FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial

Preclinical Characterization of an ANTI-CD38/CD3 T CELL-Redirecting Bispecific Antibody

The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia

A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia

Donor Cell Acute Myeloid Leukemia after Transplant for Follicular Lymphoma

JAK2V617F Hematopoietic Stem and Progenitors Are More Resistant to Chronic Blockage of IL-10 Signaling in a Murine Model of Myeloproliferative Neoplasms

FOXM1 and the NPM-ALK/STAT3 Axis Form a Novel Positive Feedback Loop in Promoting the Oncogenesis of ALK-Positive Anaplastic Large Cell Lymphoma

Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies

Insights from Comparative Serum Proteomic Profiling of Children with Sickle Cell Disease: The Effect of Hydroxyurea and Genotype on Protein Abundance

A Novel HIV Envelope Bi-Specific Killer Engager Enhances Natural Killer Cell Mediated ADCC Responses Against HIV-Infected Cells

Predicting Cerdulatinib Therapeutic Concentrations in Patients with Relapsed/Refractory B Cell Malignancies Using Preclinical Models and Clinical PK/PD and Tumor Response Correlates

CUDC-907, a Dual HDAC and PI3K Inhibitor, Potentially Targets Cancer Cells and The Microenvironment In Hematological Malignancies

Constitutive and Immunoproteasome Inhibitors Increase IκB and Decrease NF-κB Expression In Dendritic Cell

A First-In-Man Phase 1 Study Of CUDC-907, a First-In-Class Chemically-Designed Dual Inhibitor Of PI3K and HDAC In Patients With Refractory Or Relapsed Lymphoma and Multiple Myeloma

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Spleen Tyrosine Kinase Inhibitor Fostamatinib Blocks B Cell Receptor Signaling and Reduces Viability of BCR Subtype Diffuse Large B Cell Lymphoma

Harman AN, Lai J, Turville S, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood . 2011;118(2): 298-308 .

Somatic Hypermutation in Mantle Cell Lymphoma

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only